z-logo
Premium
Letter: infliximab therapy for patients with inflammatory bowel disease – some unanswered questions
Author(s) -
Srinivas N. R.
Publication year - 2015
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13385
Subject(s) - infliximab , medicine , dosing , inflammatory bowel disease , population , trough (economics) , trough concentration , disease , gastroenterology , surgery , environmental health , economics , macroeconomics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom